Manual_digital

Cuidados

Continuos

10.

11.

12.

13.

14.

BIBLIOGRAFÍA

Hesketh PJ. Chemotherapy induced nausea and vomiting. N Eng J Med 2008; 358(2):2482-

2494.

Chacón JL. Quintanar T. Martinez Barbeito MB Pangua C. Emesis Postquimioterapia Em:

Gonsález Baron M. Espinosa E. Jeliu J. de Castro J. Casado E. Zamora P. Ordóñez A. Redondo A

Belda C. Oncologia Clínica Vol 1. Madrid. Ed Momento Medico Iberoamericana, 2010. 705 – 718.

3. Barneto Aranda IC, Serrano Blanch R, Aranda Aguilar E, Antieméticos En: Diaz Rubio E,

Pérez Segura P, Oncomecum 5ª Ed. Permanyer 2013: 223 – 234.

Hesketh PJ., Kris SM., Grunberg SM, Beck T, Hainsworth JD, Harker et al.:

Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;

5(1):103-9

Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K et al.: Evaluation of

new antiemetic agents and definition of antineoplastic agent emetogenicity state of the art.

Support Care Cancer 2011; 19 (suppl 1): s43-7

Navari RM.: Management of chemotherapy induced nausea and vomiting. Drugs. 2013; 73(3):

249-62.

Hesketh PJ. Comparative review of 5 HT·3 antagonist in the treatment of acute chemotherapy

inducen nausea and vomiting. Cancer Invest, 2000. 18(2): 166 -73.

Boccia R. Gordan L. Clark G. Howell J. Grunberg S. Efficacy and tolerability of transdermal

granisetron of the control of chemotherapy induced nausea nad vomiting associated with

moderately and highly emetogenic multi-day chemotherapy. A randomized, double blind,

phase III study. Support Care Cancer 2011. 19, 1609-1617.

Botrel T., Clark O., Clark L., Paladini L., Faleiros E., Pegoretti B. Efficacy of palonosetron

compared to other serotonin inhibitors in preventing chemotherapy induced nausea and

vomiting in patients receiving moderately or highly treatment: systematic review ad meta

analysis. Support Care Cancer. 2011. 19(6): 823 – 32.

Grunberg S. Chua D. Maru A. Dinis J. De Vandry S. Boice JA et al. Single dose fosaprepitant

for the prevention of chemotherapy induced nausea and vomiting associated with cisplatin

therapy: randomized double blind study protocol- EASE. J Clin Oncol 2011. 29(11): 1495-501

García Gomez J. Pérez Lopez M. Alonso Bermejo M. Escobar Alvarez Y. Garcia Mata J. SEOM

guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013. Clin Transl

Oncol 2013. 15: 1030-1036

Roila F. Heerstedt J. Aapro M. Gralla RJ. Einhorn LH. Ballaton E. et al. Guideline update for MASCC

and ESMO in the prevention of chemotherapy and radiotherapy induced nausea and vomiting:

results of the Perugia Consensus Conference. Ann of Oncology 2010. 21 (sup 5): 232 – 243.

Bash E. Prestrud AA. Hesketh P. Kriss M. Feyer P.Somerfield MR et al. Antiemetics: American

Society of Clinical Oncology practice guideline update. J Clin Oncol 2011. 29: 4189 – 4198.

14 NCCN